
Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated February 11, 2026, "OneSource-Hikma partnership secures approval tocommercialise generic version of Ozempic® in Saudi Arabia".
Filed with NSE · · 3 pages · English

Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated February 11, 2026, "OneSource-Hikma partnership secures approval tocommercialise generic version of Ozempic® in Saudi Arabia".
OneSource Specialty Pharma Limited on 6ix
Follow OneSource Specialty Pharma into a list and get an email when it puts out news.
Follow OneSource Specialty Pharma